Echinococcosis is a human disease caused by the larval form of Taenia
echinococcus, which lives in the gut of the dog, wild canides and othe
r carnivorous animals which represent the definitive hosts and involve
s as intermediate hosts both domestic and wild animals. Humans become
accidental intermediate hosts by ingesting Taenia eggs. The main speci
es pathogenic for man are E granulosus causing cystic echinococcosis w
ith worldwide distribution and endemic in sheep and cattle breeding co
untries, and E multilocularis causing alveolar echinococcosis, with pr
eferential distribution in the northern hemisphere. After ingestion of
contaminated food, hexacanth embryos migrate by the portal system to
liver and later lung, brain and other tissues. Symptoms are related to
both cyst location and size. E granulosus infection of the central ne
rvous system (CNS) may be primary or secondary and has been estimated
to be low (2%). Sharply demarcated, spherical and intraparenchymal, cy
sts may reach a large size causing neurological symptoms. Spilling of
cyst fluid due to trauma or surgery may trigger anaphylaxis as well as
disseminated infection. Host reaction is minimal in the brain but a f
oreign giant cell reaction may develop. E multilocularis develops with
in the liver as a rapid invasive pseudomalignant growth and may metast
asize to the CNS, where estimated incidence reaches 5%. Hydatid antige
ns induce an immune reaction in the host which is helpful for the diag
nosis. DNA probes and PCR may be applied to differentiate between Echi
nococcus spp. Although the host develops an immunological protection f
rom reinfection, the parasite evades host immune attack. A wide range
of evasion mechanisms have been advanced, including a barrier for host
cells due to hydatid cyst laminated cuticle, polyclonal activation of
lymphocytes by parasite soluble antigens, and depression of host cell
immune responses. Chronic stimulation of the host by cyst fluid antig
ens leads to increased specific IgG4 production, which might act as bl
ocking antibodies against anaphlaxis suggestive of host response immun
omodulation.